Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome

Nutrition Research Reviews

Volumn 24, Issue 1, 2011, Pages 21-30

  Stoidis, Christos N ^a   Misiakos, Evangelos P ^b   Patapis, Paul ^b   Fotiadis, Constantine I ^b   Spyropoulos, Basileios G ^b  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bacterial overgrowth; Bacterial translocation; Intestinal barrier; Probiotics; Short bowel syndrome

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; GOLD STANDARD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MOLECULAR INTERACTION; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SHORT BOWEL SYNDROME; BACTERIA; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

BACTERIA; BACTERIAL TRANSLOCATION; HUMANS; INTESTINAL MUCOSA; INTESTINES; PREBIOTICS; PROBIOTICS; SHORT BOWEL SYNDROME;

EID: 79958863571     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422410000260     Document Type: Review

References (83)

1. Misiakos EP, Macheras A, Kapetanakis T, et al. (2007) Short bowel syndrome: current medical and surgical trends. J Clin Gastroenterol 41, 5-18. (Pubitemid 46045665)
2. Spencer AU, Neaga A, West B, et al. (2005) Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 242, 403-408.
3. Quirós-Tejeira RE, Ament ME, Reyen L, et al. (2004) Longterm parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 145, 157-163. (Pubitemid 38993385)
4. Gratz SW, Mykkanen H & El-Nezami HS (2010) Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol 16, 403-410.
5. Gonzalez HF, Perez NB, Malpeli A, et al. (2003) Nutrition and immunological status in long-term follow up of children with short bowel syndrome. J Parenter Enter Nutr 29, 186-191.
6. Goday PS (2009) Short bowel syndrome: how short is too short? Clin Perinatol 36, 101-110.
7. Cassaccia G, Trucchi A, Spirydakis I, et al. (2006) Congenital intestinal anomalies, neonatal short bowel syndrome, and prenatal counseling. J Pediatr Surg 41, 804-807.
8. Sigalet DL (2001) Short bowel syndrome in infants and children: an overview. Semin Pediatr Surg 10, 49-55.
9. O'Keefe SJ, Buchman AL, Fischbein TM, et al. (2006) Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 4, 6-10. (Pubitemid 43129518)
10. Wessel JJ & Kocoshis SA (2007) Nutritional management of infants with short bowel syndrome. Semin Perinatol 31, 104-111. (Pubitemid 46616963)
11. Goulet O, Baglin-Gobet S, Talbotec C, et al. (2005) Outcome and long term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 15, 95-101. (Pubitemid 40834266)
12. DiBaise JK, Young RJ & Vanderhoof JA (2004) Intestinal rehabilitation and the short bowel syndrome. Am J Gastroenterol 99, 1386-1395. (Pubitemid 39062280)
13. Juno RJ, Knott AW, Profitt SA, et al. (2004) Preventing enterocyte apoptosis after massive small bowel resection does not enhance adaptation of the intestinal mucosa. J Pediatr Surg 39, 907-911. (Pubitemid 38833780)
14. Folkman J (2007) Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg 42, 1-11.
15. Lee KD, Yamataka A, Kato Y, et al. (2006) Basic fibroblast growth factor and granulocyte colony-stimulating factor enhance mucosal surface expansion after adult small bowel transplantation without vascular reconstruction in rats. J Pediatr Surg 41, 737-741.
16. Parvadia JK, Keswani SG, Vaikunth S, et al. (2007) Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol 293, G591-G598. (Pubitemid 47435379)
17. Martin CA, Perrone EE, Longshore SW, et al. (2009) Intestinal resection induces angiogenesis within adapting intestinal villi. J Pediatr Surg 44, 1077-1083.
18. Murakami M, Sato N, Sato N, et al. (2007) Changes in lymphocyte phenotypes and cytokine production by surgical stress in a rat small intestinal resection model. J Clin Biochem Nutr 40, 216-220. (Pubitemid 46984215)
19. Diamanti A, Basso MS, Castro M, et al. (2008) Irreversible intestinal failure: prevalence and prognostic factors. J Pediatr Gastroenterol Nutr 47, 450-457.
20. Duro D, Kamin D & Duggan C (2008) Overview of pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 47, S33-S36.
21. Diamanti A, Basso MS, Castro M, et al. (2007) Prevalence of life-threatening complications in pediatric patients affected by intestinal failure. Transplant Proc 39, 1632-1633. (Pubitemid 46907921)
22. Nightingale JM (2003) Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 17, 907-929.
23. Atalay F, Ozcay N, Gundogdu H, et al. (2003) Evaluation of the outcomes of short bowel syndrome and indications for intestinal transplantation. Transplant Proc 35, 3054-3056. (Pubitemid 38102130)
24. Goulet O & Ruemmele F (2006) Causes and management of intestinal failure in children. Gastroenterology 130, S16-S28. (Pubitemid 43208856)
25. Sukhotnik I, Coran AG, Alexander Kramer A, et al. (2005) Advances in short bowel syndrome: an updated review. Pediatr Surg Int 21, 947-953. (Pubitemid 41720302)
26. Clayburgh DR, Shen L & Turner JR (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84, 282-291. (Pubitemid 41656483)
27. Quigley EMM & Quera R (2006) Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130, S78-S90. (Pubitemid 43208864)
28. Resta-Lenert S & Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997. (Pubitemid 36765291)
29. Gatt M, Reddy BS & Macfie J (2007) Review Article: bacterial translocation in the critically ill - evidence and methods of prevention. Aliment Pharmacol Ther 25, 741-757. (Pubitemid 46437210)
30. O'Brien DP, Nelson LA, Kemp CJ, et al. (2002) Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg 37, 390-394. (Pubitemid 34188160)
31. Ewaschuk J, Endersby R, Thiel D, et al. (2007) Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46, 841-850. (Pubitemid 47436131)
32. Qin HL, Shen TY, Gao ZG, et al. (2005) Effect of Lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J Gastroenterol 11, 2591-2596.
33. Cario E, Gerken G & Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374. (Pubitemid 46627595)
34. Bruewer M, Luegering A, Kucharzik T, et al. (2003) Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171, 6164-6172. (Pubitemid 37467239)
35. Zareie M, Johnson-Henry K, Jury J, et al. (2006) Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55, 1553-1560. (Pubitemid 44629200)
36. Spindler-Vesel A, Bengmark S, Vovk I, et al. (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 31, 119-126.
37. Caballero-Franco C, Keller K, De Simone C, et al. (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292, G315-G322. (Pubitemid 46090273)
38. Schrezenmeir J & De Vrese M (2001) Probiotics, prebiotics and synbiotics - approaching a definition. Am J Clin Nutr 73, 361-364.
39. De Vrese M (2003) Effects of probiotic bacteria on gastrointestinal symptoms, Helicobacter pylori activity and antibiotics-induced diarrhea. Gastroenterology 124, A560.
40. Pochard P, Gosset P, Grangette C, et al. (2002) Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110, 617-623. (Pubitemid 35178799)
41. Nagao F, Nakayama M, Muto T, et al. (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64, 2706-2708.
42. Mach T (2006) Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 57, 23-33.
43. De Roos N & Katan M (2000) Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 71, 405-411. (Pubitemid 30061217)
44. Bowen JM, Stringer AM, Gibson RJ, et al. (2007) VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6, 1449-1454. (Pubitemid 351590357)
45. Shanahan F (2002) The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 16, 915-931.
46. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361, 512-519. (Pubitemid 36173720)
47. Tappenden KA & Deutsch AS (2007) The physiological relevance of the intestinal microbiota - contributions to human health. J Am Coll Nutr 26, 679S-683S.
48. Sakata T (1987) Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal tropic factors. Br J Nutr 58, 96-103.
49. Katoh K (1995) Effects of short-chain fatty acids on exocrine and endocrine pancreatic secretion. In Physiological and Clinical Aspects of Short-Chain Fatty Acids, pp. 222-242 [J Cummings, J Rombeau and T Sakata, editors]. Cambridge: Cambridge University Press.
50. Taweechotipatr M, Iyer C, Spinler JK, et al. (2009) Lactobacillus saerimneri and Lactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities. FEMS Microbiol Lett 293, 65-72.
51. Kimoto H, Mizumachi K, Okamoto T, et al. (2004) New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 48, 75-82. (Pubitemid 38248332)
52. Roller M, Pietro Femia A, Caderni G, et al. (2004) Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 92, 931-938. (Pubitemid 40028854)
53. Matsuzaki T & Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78, 67-73. (Pubitemid 30090991)
54. Benyacoub J, Czarnecki-Maulden GL, Cavadini C, et al. (2003) Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 133, 1158-1162. (Pubitemid 36407142)
55. Baillon ML, Marshall-Jones ZV & Butterwick RF (2004) Effects of probiotic Lactobacillus acidophilus strain DSM13241 in healthy adult dogs. Am J Vet Res 65, 338-343. (Pubitemid 38332192)
56. Gibson GR, Probert HM, Van Loo J, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259-275.
57. Macfarlane S, Macfarlane GT & Cummings JH (2006) Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24, 701-714.
58. Herbert MK & Holzer P (2008) Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients - current status and future options. Clin Nutr 27, 25-41. (Pubitemid 351201851)
59. Mogilner JG, Srugo I, Lurie M, et al. (2007) Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J Pediatr Surg 42, 1365-1371. (Pubitemid 47238326)
60. Eizaguirre I, Urkia NG, Asensio AB, et al. (2002) Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 37, 699-702. (Pubitemid 34517437)
61. García-Urkia N, Asensio AB, Zubillaga Azpiroz I, et al. (2002) Beneficial effects of Bifidobacterium lactis in the prevention of bacterial translocation in experimental short bowel syndrome (article in Spanish). Cir Pediatr 15, 162-165.
62. Peuranen S, Tiihonen K, Apajalahti J, et al. (2004) Combination of polydextrose and lactitol affects microbial ecosystem and immune responses in rat gastrointestinal tract. Br J Nutr 91, 905-914. (Pubitemid 38931454)
63. Zyrek AA, Cichon C, Helms S, et al. (2007) Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9, 804-816. (Pubitemid 46231983)
64. Yan F & Polk DB (2002) Probiotic bacterium prevents cytokine- induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959-50965. (Pubitemid 36042264)
65. Schlee M, Harder J, Koeten B, et al. (2008) Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clin Exp Immunol 151, 528-535. (Pubitemid 351160737)
66. Madsen K, Cornish A, Soper P, et al. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591. (Pubitemid 32822573)
67. Resta-Lenert S & Barrett K (2009) Modulation of intestinal barrier properties by probiotics: role in reversing colitis. Ann N Y Acad Sci 1165, 175-182.
68. Osman N, Adawi D, Ahrne S, et al. (2007) Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Dig Liv Dis 39, 849-856. (Pubitemid 47215581)
69. Wu J, Tang Q, Feng Y, et al. (2007) Nutrition assessment in children with short bowel syndrome weaned off parenteral nutrition: a long-term follow-up study. J Pediatr Surg 42, 1372-1376. (Pubitemid 47243662)
70. Fukushima Y, Kawata Y, Hara H, et al. (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 30, 39-44. (Pubitemid 28370327)
71. Mohamadzadeh M, Olson S, Kalina WV, et al. (2005) Lactobacilli activate human dendritic cells that skew T-cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 22, 2880-2885. (Pubitemid 40299885)
72. McNaught CE, Woodcock NP, MacFie J, et al. (2002) A prospective randomised study of the probiotic Lactobacillus plantarum 299 V on indices of gut barrier function in elective surgical patients. Gut 51, 827-831. (Pubitemid 35408604)
73. McNaught CE, Woodcock NP, Anderson AD, et al. (2005) A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 24, 211-219. (Pubitemid 40392804)
74. Howard JC, Reid G & Gan BS (2004) Probiotics in surgical wound infections: current status. Clin Invest Med 27, 274-281. (Pubitemid 39664811)
75. Alfaleh K, Anabrees J & Bassler D (2009) Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 97, 93-99.
76. KanamoriY, SugiyamaM,HashizumeK, et al. (2004)Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 39, 1686-1692.
77. Kanamori Y, Hashizume K, Sugiyama M, et al. (2001) Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci 46, 2010-2016.
78. Uchida K, Takahashi T, Inoue M, et al. (2007) Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int 23, 243-248. (Pubitemid 46295032)
79. Jain PK, McNaught CE, Anderson ADG, et al. (2004) Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 23, 467-475. (Pubitemid 39107024)
80. Sentongo TA, Cohran V, Korff S, et al. (2008) Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. J Pediatr Gastroenterol Nutr 46, 41-47.
81. Snydman DR (2008) The safety of probiotics. Clin Infect Dis 46, S104-S111, discussion S144-S151.
82. De Groote MA, Frank DN, Dowell E, et al. (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24, 278-280. (Pubitemid 40365870)
83. Kunz AN, Noel JM & Fairchok MP (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 38, 457-458.